ARTICLE | Company News
Roche, Genentech in GA101 deal
October 4, 2008 12:43 AM UTC
The companies partnered to jointly develop and commercialize Roche's GA101 (R7159). The humanized mAb against CD20 is in international Phase I/II testing for CD20-positive B cell malignancies. Genente...